Table 5 Simple linear regression model of factors predicting difference in WBC count pre-vax vs. post-vax 1 in CT-treated group
Characteristic | Difference between WBC count pre- vs. post-vax 1 in the CT group | |||
|---|---|---|---|---|
N | Beta | 95% CI | p-value | |
Gender | 63 | 0.461 | ||
Female | — | — | ||
Male | -1.0 | -3.6, 1.7 | ||
Age | 63 | -0.03 | -0.14, 0.08 | 0.606 |
BMI | 63 | -0.14 | -0.46, 0.17 | 0.372 |
Concomitant disease | 63 | 0.637 | ||
No | — | — | ||
Yes | 0.66 | -2.1, 3.5 | ||
Cardiovascular disease | 63 | 0.549 | ||
No | — | — | ||
Yes | -0.78 | -3.4, 1.8 | ||
Metabolic disease | 63 | 0.794 | ||
No | — | — | ||
Yes | -0.43 | -3.7, 2.8 | ||
Hematologic disease | 63 | 0.627 | ||
No | — | — | ||
Yes | 2.5 | -7.8, 13 | ||
Immune-mediated | 63 | < 0.001 | ||
No | — | — | ||
Yes | 15 | 9.1, 21 | ||
Lung disease | 63 | 0.817 | ||
No | — | — | ||
Yes | 0.55 | -4.2, 5.3 | ||
Liver disease | 63 | 0.938 | ||
No | — | — | ||
Yes | -0.24 | -6.3, 5.8 | ||
Allergy to drugs | 63 | 0.904 | ||
No | — | — | ||
Yes | -0.27 | -4.6, 4.1 | ||
Endocrine disease | 63 | 0.950 | ||
No | — | — | ||
Yes | -0.23 | -7.6, 7.1 | ||
Advanced disease | 63 | 0.225 | ||
No | — | — | ||
Yes | -2.3 | -6.2, 1.5 | ||
Antibody before vaccine | 56 | 0.412 | ||
Negative | — | — | ||
Positive | -1.6 | -5.5, 2.3 | ||
Antibody Titer one-month | 52 | 0.880 | ||
Negative | — | — | ||
Positive | -0.18 | -2.5, 2.2 | ||
Antibody Titer at 3-months | 35 | 0.945 | ||
Negative | — | — | ||
Positive | -0.07 | -2.0, 1.9 | ||
Antibody Titer at 6-months | 27 | 0.485 | ||
Negative | — | — | ||
Positive | -1.4 | -5.4, 2.6 | ||
Growth factors use | 63 | 0.064 | ||
No | — | — | ||
Yes | 2.5 | -0.15, 5.2 | ||